BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
BioInvent International Total Assets (Quarterly): 107.86M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 107.86M |
| June 30, 2024 | 112.97M |
| March 31, 2024 | 124.72M |
| December 31, 2023 | 139.09M |
| September 30, 2023 | 135.87M |
| June 30, 2023 | 147.22M |
| March 31, 2023 | 159.99M |
| December 31, 2022 | 164.28M |
| September 30, 2022 | 157.59M |
| June 30, 2022 | 152.35M |
| March 31, 2022 | 149.50M |
| December 31, 2021 | 159.98M |
| September 30, 2021 | 172.88M |
| June 30, 2021 | 186.45M |
| March 31, 2021 | 186.57M |
| December 31, 2020 | 98.02M |
| September 30, 2020 | 78.47M |
| June 30, 2020 | 26.90M |
| March 31, 2020 | 19.38M |
| December 31, 2019 | 24.20M |
| September 30, 2019 | 27.99M |
| June 30, 2019 | 34.16M |
| March 31, 2019 | 15.20M |
| December 31, 2018 | 13.41M |
| September 30, 2018 | 16.30M |
| Date | Value |
|---|---|
| June 30, 2018 | 20.44M |
| March 31, 2018 | 27.25M |
| December 31, 2017 | 20.79M |
| September 30, 2017 | 23.90M |
| June 30, 2017 | 26.04M |
| March 31, 2017 | 26.69M |
| December 31, 2016 | 30.48M |
| September 30, 2016 | 25.35M |
| June 30, 2016 | 28.76M |
| March 31, 2016 | 7.143M |
| December 31, 2015 | 6.475M |
| September 30, 2015 | 8.260M |
| June 30, 2015 | 11.10M |
| March 31, 2015 | 5.746M |
| December 31, 2014 | 9.560M |
| September 30, 2014 | 13.94M |
| June 30, 2014 | 17.70M |
| March 31, 2014 | 8.347M |
| December 31, 2013 | 12.70M |
| September 30, 2013 | 8.641M |
| June 30, 2013 | 8.568M |
| March 31, 2013 | 13.72M |
| December 31, 2012 | 17.93M |
| September 30, 2012 | 27.71M |
| June 30, 2012 | 30.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.38M
Minimum
Mar 2020
186.57M
Maximum
Mar 2021
125.21M
Average
143.15M
Median
Total Assets (Quarterly) Benchmarks
| Abliva AB | 7.132M |
| Oncopeptides AB | 27.02M |
| Hansa Biopharma AB | 93.30M |
| BioArctic AB | 106.66M |
| Camurus AB | 353.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.369M |
| Shareholders Equity (Quarterly) | 99.49M |
| Current Ratio | 13.29 |